By Di Pierro F, et al. Published June 24, 2021 in the International Journal of General Medicine Abstract Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential...
By Zeynep Tufekci Back when a viral pandemic killing millions around the world was just the plot of a scary movie, the film “Contagion” was lauded for how accurately it depicted the way such an outbreak would occur. On the science of viral contagion, it was quite...
— Researchers urge caution, but a clearer picture starts to emerge by Molly Walker A so-called "mix and match" COVID vaccine series using a different booster than the primary series was safe and produced an increase in immune response comparable to or greater than...
By Jean-Louis Montastruc, published July 11, 2021 in Fundamental & Clinical Pharmacology Abstract Several vaccines are being developed as part of the COVID-19 pandemic. The results of clinical trials for these vaccines were published with efficacy values of more...
Some poorer countries are paying more and waiting longer for the company’s vaccine than the wealthy — if they have access at all. By Rebecca Robbins Moderna, whose coronavirus vaccine appears to be the world’s best defense against Covid-19, has been...
Researchers from the University of California, Los Angeles, (USC) University of Southern California (USC), and the Cleveland Clinic conducted a meta-analysis of studies probing the risk associated with SARS-CoV-2 reinfection among those previously infected with...
Merck’s molnupiravir has certainly received a lot of good press over the past days since the New Jersey-based pharmaceutical company announced its clinical trial demonstrates positive results. They will be expeditiously working to file for an emergency use...
Vaccine makers are betting that the mRNA technology powering two successful Covid vaccines will help curb the tragic global death toll from the flu. By Carl Zimmer As the world grapples with Covid-19, influenza isn’t getting much attention these days. But the...
Trial Site News is skeptical on Covid vaccines so we post selectively from their fact-based reports. The fact that Scandinavian countries are taking the steps described below underscores the essentially variable meaning of "follow the science" in different countries...
By Venice Servellita, et al. PREPrint ~ August 25, 2021 with Commentary from TrialSiteNews Below Abstract Associations between vaccine breakthrough cases and infection by SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analyzed...
By S. V. Subramanian & Akhil Kumar Published September 30, 2021 in European Journal of Epidemiology Vaccines currently are the primary mitigation strategy to combat COVID-19 around the world. For instance, the narrative related to the ongoing surge of new cases in...
By Michel C. Nussenzweig, Senior Physician, Investigator, Howard Hughes Medical Institute, Zanvil A. Cohn and Ralph M. Steinman Professor, Laboratory of Molecular Immunology This news story (August 24 2021) has been updated to reflect the publication on October 7,...
By Annaliese Griffin If you’ve dipped even a toe into the kiddie pool of modern parenting politics, then you’re probably aware that it’s actually a shark tank. Confess your love for the convenience of school lunches and expect a pitying smile. A far...
Myocarditis, a rare side effect, occurs mostly after the second dose. So in some countries, officials are trying out single doses for children. By Apoorva Mandavilli Even as parents in the United States wrestle with difficult questions over vaccinating their children...
By Kathleen Doheny Soon after Merck announced on October 1 that it would ask federal regulators for emergency use authorization (EUA) for its auspicious new COVID-19 pill, the accolades began. Former US Food and Drug Administration (FDA) chief Scott...